1. Home
  2. KYTX vs SMHI Comparison

KYTX vs SMHI Comparison

Compare KYTX & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • SMHI
  • Stock Information
  • Founded
  • KYTX 2018
  • SMHI 1989
  • Country
  • KYTX United States
  • SMHI United States
  • Employees
  • KYTX N/A
  • SMHI N/A
  • Industry
  • KYTX
  • SMHI Marine Transportation
  • Sector
  • KYTX
  • SMHI Consumer Discretionary
  • Exchange
  • KYTX NYSE
  • SMHI Nasdaq
  • Market Cap
  • KYTX 166.4M
  • SMHI 189.9M
  • IPO Year
  • KYTX 2024
  • SMHI N/A
  • Fundamental
  • Price
  • KYTX $3.41
  • SMHI $6.78
  • Analyst Decision
  • KYTX Buy
  • SMHI
  • Analyst Count
  • KYTX 5
  • SMHI 0
  • Target Price
  • KYTX $23.20
  • SMHI N/A
  • AVG Volume (30 Days)
  • KYTX 308.0K
  • SMHI 162.3K
  • Earning Date
  • KYTX 02-12-2025
  • SMHI 02-27-2025
  • Dividend Yield
  • KYTX N/A
  • SMHI N/A
  • EPS Growth
  • KYTX N/A
  • SMHI N/A
  • EPS
  • KYTX N/A
  • SMHI N/A
  • Revenue
  • KYTX N/A
  • SMHI $274,636,000.00
  • Revenue This Year
  • KYTX N/A
  • SMHI $6.04
  • Revenue Next Year
  • KYTX N/A
  • SMHI $11.18
  • P/E Ratio
  • KYTX N/A
  • SMHI N/A
  • Revenue Growth
  • KYTX N/A
  • SMHI 3.89
  • 52 Week Low
  • KYTX $3.22
  • SMHI $5.80
  • 52 Week High
  • KYTX $30.60
  • SMHI $15.36
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 37.34
  • SMHI 49.67
  • Support Level
  • KYTX $3.22
  • SMHI $6.90
  • Resistance Level
  • KYTX $3.53
  • SMHI $7.28
  • Average True Range (ATR)
  • KYTX 0.25
  • SMHI 0.34
  • MACD
  • KYTX 0.00
  • SMHI 0.04
  • Stochastic Oscillator
  • KYTX 13.46
  • SMHI 37.25

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides world-wide marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations including wind farms; handle anchors and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico); Africa and Europe; Middle East and Asia and Latin America.

Share on Social Networks: